Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Albert Einstein College of Medicine of Yeshiva University National Institutes of Health (NIH) |
---|---|
Information provided by: | Albert Einstein College of Medicine of Yeshiva University |
ClinicalTrials.gov Identifier: | NCT00707694 |
We believe extreme longevity is due to specific genes which function to delay aging and prevent disease. The purpose of our research is to identify the genes/mutations associated with healthier aging; to understand the biological functions of these genes/mutations; and to develop therapies to replicate these preservative genetic activities in individuals who do not have the genetic profile for longevity.
Condition |
---|
Extreme Longevity |
Study Type: | Observational |
Study Design: | Case Control, Prospective |
Official Title: | Searching for Longevity Genes in the Historically Unique Ashkenazi Jewish Population |
Estimated Enrollment: | 1500 |
Study Start Date: | July 1998 |
Groups/Cohorts |
---|
Probands
Ashkenazi Jews ages 95 and older
|
Offspring
Ashkenazi Jewish offspring of Ashkenazi Jewish parent(s) who lived to at least the age of 95
|
Controls
Ashkenazi Jewish people with no family history of longevity
|
Ages Eligible for Study: | 65 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Ashkenazi Jews:
Ages 95 and older, their offspring and control group with no family history of longevity.
Inclusion Criteria:
Exclusion Criteria:
Contact: Deborah Davidson, MBA | 718-430-3237 | longevity@aecom.yu.edu |
United States, New York | |
Hebrew Home Riverdale | Recruiting |
Riverdale, New York, United States, 10471 | |
Contact: Charlotte Dell, LMSW 718-581-1139 |
Principal Investigator: | Nir Barzilai, MD | Albert Einstein College of Medicine of Yeshiva University |
Responsible Party: | Albert Einstein College of Medicine of Yeshiva University ( Nir Barzilai, MD ) |
Study ID Numbers: | 1998-125 |
Study First Received: | June 27, 2008 |
Last Updated: | June 30, 2008 |
ClinicalTrials.gov Identifier: | NCT00707694 |
Health Authority: | United States: Institutional Review Board |
95 years of age and older |